» Articles » PMID: 20463879

Liver and Adipose Expression Associated SNPs Are Enriched for Association to Type 2 Diabetes

Abstract

Genome-wide association studies (GWAS) have demonstrated the ability to identify the strongest causal common variants in complex human diseases. However, to date, the massive data generated from GWAS have not been maximally explored to identify true associations that fail to meet the stringent level of association required to achieve genome-wide significance. Genetics of gene expression (GGE) studies have shown promise towards identifying DNA variations associated with disease and providing a path to functionally characterize findings from GWAS. Here, we present the first empiric study to systematically characterize the set of single nucleotide polymorphisms associated with expression (eSNPs) in liver, subcutaneous fat, and omental fat tissues, demonstrating these eSNPs are significantly more enriched for SNPs that associate with type 2 diabetes (T2D) in three large-scale GWAS than a matched set of randomly selected SNPs. This enrichment for T2D association increases as we restrict to eSNPs that correspond to genes comprising gene networks constructed from adipose gene expression data isolated from a mouse population segregating a T2D phenotype. Finally, by restricting to eSNPs corresponding to genes comprising an adipose subnetwork strongly predicted as causal for T2D, we dramatically increased the enrichment for SNPs associated with T2D and were able to identify a functionally related set of diabetes susceptibility genes. We identified and validated malic enzyme 1 (Me1) as a key regulator of this T2D subnetwork in mouse and provided support for the association of this gene to T2D in humans. This integration of eSNPs and networks provides a novel approach to identify disease susceptibility networks rather than the single SNPs or genes traditionally identified through GWAS, thereby extracting additional value from the wealth of data currently being generated by GWAS.

Citing Articles

The Roles of White Adipose Tissue and Liver NADPH in Dietary Restriction-Induced Longevity.

Jamerson L, Bradshaw P Antioxidants (Basel). 2024; 13(7).

PMID: 39061889 PMC: 11273496. DOI: 10.3390/antiox13070820.


Malic enzyme 1 knockout has no deleterious phenotype and is favored in the male germline under standard laboratory conditions.

Alektiar J, Shan M, Radyk M, Zhang L, Halbrook C, Lin L PLoS One. 2024; 19(6):e0303577.

PMID: 38843233 PMC: 11156412. DOI: 10.1371/journal.pone.0303577.


Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis.

Fan Y, He J, Shi L, Zhang M, Chen Y, Xu L Acta Diabetol. 2024; 61(8):1053-1068.

PMID: 38691241 DOI: 10.1007/s00592-024-02278-1.


Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease.

Merchant J, Zhu K, Henrion M, Zaidi S, Lau B, Moein S Commun Biol. 2023; 6(1):503.

PMID: 37188718 PMC: 10185548. DOI: 10.1038/s42003-023-04791-5.


Malic Enzyme 1 (ME1) Promotes Adiposity and Hepatic Steatosis and Induces Circulating Insulin and Leptin in Obese Female Mice.

Simmen F, Pabona J, Al-Dwairi A, Alhallak I, Montales M, Simmen R Int J Mol Sci. 2023; 24(7).

PMID: 37047583 PMC: 10095602. DOI: 10.3390/ijms24076613.


References
1.
Emilsson V, Thorleifsson G, Zhang B, Leonardson A, Zink F, Zhu J . Genetics of gene expression and its effect on disease. Nature. 2008; 452(7186):423-8. DOI: 10.1038/nature06758. View

2.
Koyama K, Chen G, Lee Y, Unger R . Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol. 1997; 273(4):E708-13. DOI: 10.1152/ajpendo.1997.273.4.E708. View

3.
Frayling T . Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007; 8(9):657-62. DOI: 10.1038/nrg2178. View

4.
Perry J, McCarthy M, Hattersley A, Zeggini E, Weedon M, Frayling T . Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes. 2009; 58(6):1463-7. PMC: 2682674. DOI: 10.2337/db08-1378. View

5.
Chen Y, Zhu J, Lum P, Yang X, Pinto S, MacNeil D . Variations in DNA elucidate molecular networks that cause disease. Nature. 2008; 452(7186):429-35. PMC: 2841398. DOI: 10.1038/nature06757. View